Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding - An autoradiographic analysis

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 3, 1999, Pages 178-186

  Rogoz, Renata ^a   Dziedzicka Wasylewska, Marta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; Autoradiography; Dopamine receptors; Rat brain

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; APOMORPHINE; CITALOPRAM; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; FLUOXETINE; IMIPRAMINE; MIANSERIN; QUINPIROLE; RACLOPRIDE; RADIOLIGAND; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; RAT; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

EID: 0033001623     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005340     Document Type: Article

References (49)

1. 3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol 146:113-120
2. Arnt J, Hyttel J, Fredericson-Overo K (1984) Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotoninergic functions. Pol J Pharmacol Pharm 36:221-230
3. Battaglia A, Norman AB, Hess EJ, Creese I (1986) Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by Dl dopamine receptors, guanine nucleotides and sodium fluoride. J Neurochem 4:1180-1185
4. 3H-spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 49:201-202
5. Delini-Stula A, Vassout A (1979) Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment. Eur J Pharmacol 58:443-451
6. 3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system. Eur J Pharmacol 167:299-303
7. Dziedzicka-Wasylewska M, Rogoż R, Klimek V, Maj J (1997) Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain. J Neural Transm 104:515-524
8. 3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain. Eur J Pharmacol 211:189-194
9. Green AR, Deakin JFW (1980) Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin - and dopamine mediated behavior. Nature 285:232-235
10. Hall H, Wedel I (1986) Comparison between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Acta Pharmacol Toxicol 58:368-373
11. Harro J, Oreland L (1996) Depression as a speading neuronal adjustment disorder. Eur Neuropsychopharmacol 6:207-223
12. Hyttel J (1982) Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277-295
13. Hyttel J, Fredericson-Overo K, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5HT-uptake inhibitor, citalopram. Psychopharmacology 83:20-27
14. Jongen-Relo AL, Docter GJ, Jonker AJ, Vreugdenhil E, Groenewegen HJ, Voorn P (1994) Differential effects of dopamine depletion on the binding and mRNA levels of dopamine receptors in the shell and core of the rat nucleus accumbens. Mol Brain Res 25:333-338
15. Kafoe WF, De Ridder JJ, Leonard BE (1976) The effect of a tetracyclic antidepressant compound, Org GB94, on the turnover of biogenic amines in rat brain. Biochem Pharmacol 25:2455-2460
16. Klimek V, Maj J (1989a) Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2 receptors. J Pharm Pharmacol 41:555-558
17. 3H]spiperone to dopaminergic receptors. In: Serra G, Gessa GL (eds) Advances in the biosciences. Pergamon, Oxford, New York
18. 3H]SCH 23390 binding sites in the rat striatum and limbic system. Eur J Pharmacol 139:163-169
19. 3H]raclopride. A potency substituted benzamine drug with high affinity for dopamine D2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259
20. Leff P (1995) The two-state model of receptor activation. Trends Pharmacol Sci 16:89-97
21. 3H]quinpirole, identification of a discrete population of putative D3 receptors. Synapse 14:90-95
22. 3H]quinpirole binding to D2-like dopamine receptors in rat brain. J Pharmacol Exp Ther 262:929-935
23. Maj J, Wȩdzony K (1985) Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. J Pharm Pharmacol 37:362-364
24. Maj J, Wȩdzony K (1988) The influence of oxaprotyline enantiomers given repeatedly on the behavioural effects of D-amphetamine and dopamine injected into the nucleus accumbens. Eur J Pharmacol 145:97-103
25. Maj J, Rogóż Z, Skuza G, Sowińska H (1984) Repeated treatment with antidepressant drugs increases the behavioral response to apomorphine. J Neural Transm 60:273-282
26. Maj J, Wȩdzony K, Klimek V (1987) Desipramine given repeatedly enhances behavioural effects of dopamine and D-amphetamine injected into the nucleus accumbens. Eur J Pharmacol 140:179-185
27. Maj J, Rogóż Z, Skuza G, Sowińska H (1989) Antidepressants given repeatedly increase the behavioural effect of dopamine D2 agonists. J Neural Transm 78:1-8
28. 3H] N-0437, to dopamine D2 receptors in the rat brain. Eur J Pharmacol 304:49-54
29. Maj J, Dziedzicka-Wasylewska M, Rogoż R, Rogóż Z (1998) Effect of antidepressant drugs administered repeatedly on the rat dopamine D3 receptors in the rat brain. Eur J Pharmacol 351:31-37
30. 3H]quinpirole binding to human dopamine D2 and D3 receptors, effects of ions guanine nucleotides. J Pharmacol Exp Ther 274:790-797
31. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ (1990) Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary, an in situ hybrydization-receptor autoradiographic analysis. J Neurosci 10:2586-2600
32. Marshall RJ (1983) The pharmacology of mianserin - an update. Br J Clin Pharmacol 15 [Suppl 2]:263-272
33. Martin KF, Phillips I, Cheetham SC, Heal DJ (1995) Dopamine D2 receptors, a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments. Pharmacol Biochem Behav 51:565-569
34. Martin-Iverson MT, Leclere JF, Fibiger HC (1983) Cholinergicdopaminergic interactions and the mechanism of action of antidepressants. Eur J Pharmacol 94:193-201
35. 3H]spiperone. Life Sci 34:2507-2514
36. 2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. Eur J Pharmacol 153:89-95
37. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, Sydney
38. Pinder RM, Delft AML van (1983) The potential therapeutic role of the enantiomers and metabolites of mianserin. Br J Clin Pharmacol 15 [Suppl 2]:269-273
39. Płaźnik A, Kostowski W (1987) The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study. Eur J Pharmacol 135:389-396
40. Prisco S, Esposito E (1995) Differential effects of acute and chronic fluoxetine administration on spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br J Pharmacol 116:1923-1230
41. Randrup A, Munkvad I, Fog R (1975) Mania, depression and brain dopamine. In: Essman WB, Valzelli L (eds) Current developments in psychopharmacology. Spectrum, New York, p 206
42. Richelson E (1994) Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clin Proc 69:1069-1081
43. Seeman P, Grigoriadis D (1987) Dopamine receptors in brain and periphery. Neurochem Int 10:1-25
44. Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL (1990) Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res 527:234-243
45. Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74:195-206
46. Weiland GA, Minneman KP, Molinoff PB (1979) Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor. Nature 281:114-117
47. Willner P, Montgomery A (1981) Behavioural changes during withdrawal from the tricyclic antidepressant desmethylimipramine (DMI). I. Interactions with amphetamine. Psychopharmacology 75:54-59
48. Wong PT-H, Feng H, Teo WL (1995) Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonist and uptake inhibitors. Neurosci Res 23:115-119
49. Wood MD, Thomas DR, Watkins CJ, Newberry NR (1993) Stereoselective interaction of mianserin with 5-HT3 receptors. J Pharm Pharmacol 45:711-714